Aditxt (ADTX) News Today $1.74 -0.08 (-4.40%) Closing price 04:00 PM EasternExtended Trading$1.72 -0.02 (-1.15%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Aditxt Announces Termination of Arrangement Agreement With Appili TherapeuticsMay 19 at 8:48 PM | finance.yahoo.comAditxt Discusses Strategic Focus and Growth PlansMay 19 at 6:10 PM | tipranks.comAppili Therapeutics Faces Termination of Agreement with AditxtMay 19 at 8:50 AM | tipranks.comAditxt Ends Agreement with Appili TherapeuticsMay 19 at 8:50 AM | tipranks.comAppili Therapeutics Provides Update on Arrangement with Aditxt, Inc.May 19 at 8:28 AM | financialpost.comUpcoming Aditxt Weekly Update to Feature Dr. Shahrokh Shabahang, Chief Innovation Officer (CIO) of Aditxt™, and Dr. Friedrich Kapp, Co-CEO of Adimune™, to Discuss Progress of Lead Therapeutic Candidate ADI-100™May 2, 2025 | businesswire.comAditxt’s Subsidiary Pearsanta Gets IRB ApprovalApril 22, 2025 | tipranks.comDr. Charles Howe of the Mayo Clinic's Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt's Subsidiary Adimune™April 17, 2025 | businesswire.comAditxt Subsidiary Adimune Announces Positive Results from Mayo Clinic Pre-Clinical Studies to Support FDA and European Regulatory Submissions for Type 1 Diabetes, Psoriasis ...April 15, 2025 | seekingalpha.comAditxt Regains Nasdaq Compliance with Bid PriceApril 14, 2025 | tipranks.comAditxt announces results from ADI-100 studyApril 14, 2025 | markets.businessinsider.comAditxt Weekly Update to Highlight Recent Events, Including Regaining Compliance with Nasdaq Listing RequirementsApril 11, 2025 | businesswire.comWhy Aditxt Inc. (ADTX) Went Down On Thursday?April 10, 2025 | msn.comAditxt regains compliance with NasdaqApril 9, 2025 | msn.comAditxt, Inc. (NASDAQ: ADTX) Regains Compliance with Nasdaq Listing RequirementsApril 9, 2025 | finance.yahoo.comAditxt, Inc. Discusses Appili Therapeutics Acquisition PlansApril 7, 2025 | tipranks.comAppili Therapeutics CEO to join Aditxt CEO for weekly update on April 4April 3, 2025 | markets.businessinsider.comAditxt, Inc. Updates on Pearsanta’s Strategic AcquisitionMarch 31, 2025 | tipranks.comUpcoming Aditxt Weekly Update to Highlight Pearsanta's Acquisition of the Adductomics-Based CaSe Platform and its Potential for Early Cancer DetectionMarch 28, 2025 | businesswire.comAditxt Subsidiary Pearsanta Acquires Key Patents For Early Cancer DetectionMarch 26, 2025 | nasdaq.comEvofem Reports Fourth Consecutive Year of Net Sales GrowthMarch 24, 2025 | finance.yahoo.comAditxt, Inc. Highlights Strategic Partnership with EvofemMarch 24, 2025 | tipranks.comAditxt Insider Trading Activity | NASDAQ:ADTX | BenzingaMarch 19, 2025 | benzinga.comBiotech Stocks To Consider - March 18thAditxt, AbbVie, Thermo Fisher Scientific, Vertex Pharmaceuticals, Danaher, Cencora, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares in companies that develop, produce, and commercialize biotechnology-based products anMarch 19, 2025 | marketbeat.comAppili Therapeutics expects Aditxt transaction to close in Q1March 19, 2025 | markets.businessinsider.comUS Equities Markets End Lower Tuesday as Federal Reserve Kicks Off Policy MeetingMarch 18, 2025 | msn.comAditxt Stock Price, Quotes and Forecasts | NASDAQ:ADTX | BenzingaMarch 18, 2025 | benzinga.comADiTx Therapeutics trading halted, news pendingMarch 15, 2025 | markets.businessinsider.comAditxt, Inc. Announces Reverse Stock Split PlanMarch 12, 2025 | tipranks.comAditxt announces 1-for-250 reverse stock split effective March 17March 12, 2025 | markets.businessinsider.comAditxt, Inc. (NASDAQ: ADTX) Announces 1-for-250 Reverse Stock Split Effective at the Open of Trading on March 17, 2025March 12, 2025 | businesswire.comAditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany ...March 7, 2025 | businesswire.comAditxt’s Adimune to ship substances for product formulation of of ADI-100March 6, 2025 | markets.businessinsider.comAditxt approves reverse stock split, adjourns special meetingMarch 5, 2025 | investing.comIs the Market Bullish or Bearish on Aditxt?March 1, 2025 | benzinga.comAditxt, Inc. Discusses Pearsanta’s Planned IPO and InnovationsFebruary 24, 2025 | tipranks.comAditxt subsidiary Persanta engages Dominary Securities for IPOFebruary 21, 2025 | markets.businessinsider.comAditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025February 21, 2025 | businesswire.comAppili Therapeutics Inc.: Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025February 15, 2025 | finanznachrichten.deAditx Therapeutics stock hits 52-week low at $0.12January 21, 2025 | msn.comAditxt to explore taking Pearsanta subsidiary publicJanuary 13, 2025 | markets.businessinsider.comAditxt, Inc. Plans IPO for Pearsanta in 2025January 13, 2025 | tipranks.comAditxt’s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection PlatformJanuary 13, 2025 | finance.yahoo.comAditxt Advances ADI-100 Therapy to Human TrialsDecember 12, 2024 | tipranks.comAditxt extends merger agreement end date to January 2025November 21, 2024 | investing.comAppili Therapeutics shareholders vote in favor of Aditxt transactionNovember 14, 2024 | markets.businessinsider.comEvofem Biosciences Announces Financial Results for the Third Quarter of 2024November 14, 2024 | prnewswire.comAditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of SharesNovember 8, 2024 | finance.yahoo.comAditxt, Inc. Focuses on Growth Amid Nasdaq ComplianceNovember 6, 2024 | markets.businessinsider.comAditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary AdifemNovember 6, 2024 | businesswire.com Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Email Address ADTX Media Mentions By Week ADTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADTX News Sentiment▼1.520.65▲Average Medical News Sentiment ADTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADTX Articles This Week▼61▲ADTX Articles Average Week Get Aditxt News Delivered to You Automatically Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Capstone News Kiromic BioPharma News TFF Pharmaceuticals News Petros Pharmaceuticals News TC Biopharm News NuCana News Virpax Pharmaceuticals News Universe Pharmaceuticals News Vincerx Pharma News Polyrizon News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADTX) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aditxt, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aditxt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADTX Stock Free ADTX Stock Alerts